izpis_h1_title_alt

Exploring the 5-substituted 2-aminobenzothiazole-based DNA gyrase B inhibitors active against ESKAPE pathogens
ID Sterle, Maša (Author), ID Durcik, Martina (Author), ID Kikelj, Danijel (Author), ID Zidar, Nace (Author), ID Peterlin-Mašič, Lucija (Author), ID Ilaš, Janez (Author), ID Tomašič, Tihomir (Author), ID Cotman, Andrej Emanuel (Author), ID Zega, Anamarija (Author), et al.

.pdfPDF - Presentation file, Download (4,52 MB)
MD5: D4130DC5969ECD8F61DA5AF19ECB3A1F
URLURL - Source URL, Visit https://pubs.acs.org/doi/10.1021/acsomega.3c01930 This link opens in a new window

Abstract
We present a new series of 2-aminobenzothiazole-based DNA gyrase B inhibitors with promising activity against ESKAPE bacterial pathogens. Based on the binding information extracted from the cocrystal structure of DNA gyrase B inhibitor A, in complex with Escherichia coli GyrB24, we expanded the chemical space of the benzothiazole-based series to the C5 position of the benzothiazole ring. In particular, compound E showed low nanomolar inhibition of DNA gyrase (IC$_{50}$ < 10 nM) and broad-spectrum antibacterial activity against pathogens belonging to the ESKAPE group, with the minimum inhibitory concentration < 0.03 μg/mL for most Gram-positive strains and 4–16 μg/mL against Gram-negative E. coli, Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae. To understand the binding mode of the synthesized inhibitors, a combination of docking calculations, molecular dynamics (MD) simulations, and MD-derived structure-based pharmacophore modeling was performed. The computational analysis has revealed that the substitution at position C5 can be used to modify the physicochemical properties and antibacterial spectrum and enhance the inhibitory potency of the compounds. Additionally, a discussion of challenges associated with the synthesis of 5-substituted 2-aminobenzothiazoles is presented.

Language:English
Keywords:bacteria, genetics, inhibitors, organic acids, peptides, proteins
Work type:Article
Typology:1.01 - Original Scientific Article
Organization:FFA - Faculty of Pharmacy
Publication status:Published
Publication version:Version of Record
Year:2023
Number of pages:Str. 24387-24395
Numbering:Vol. 8, iss. 27
PID:20.500.12556/RUL-152634 This link opens in a new window
UDC:579.8:615.2
ISSN on article:2470-1343
DOI:10.1021/acsomega.3c01930 This link opens in a new window
COBISS.SI-ID:157232131 This link opens in a new window
Publication date in RUL:01.12.2023
Views:194
Downloads:25
Metadata:XML RDF-CHPDL DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:ACS omega
Shortened title:ACS omega
Publisher:American Chemical Society
ISSN:2470-1343
COBISS.SI-ID:525873945 This link opens in a new window

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Secondary language

Language:Slovenian
Keywords:inhibitorji, organske kisline, proteini, bakterije, genetika, peptidi

Projects

Funder:ARRS - Slovenian Research Agency
Project number:P1-0208
Name:Farmacevtska kemija: načrtovanje, sinteza in vrednotenje učinkovin

Funder:ARRS - Slovenian Research Agency
Project number:J1-3031
Name:Razvoj novih zaviralcev bakterijskih topoizomeraz za boj proti odpornim infekcijam

Funder:ARRS - Slovenian Research Agency
Project number:BI-FR/22-23-PROTEUS-004

Funder:UKRI - UK Research and Innovation
Funding programme:BBSRC, Institute Strategic Programme
Project number:BB/P012523/1

Funder:EC - European Commission
Funding programme:FP7
Project number:115583
Name:European Gram Negative Antibacterial Engine
Acronym:ENABLE

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back